Effective May 9, 2016, Baylor Miraca Genetics Laboratories (BMGL) will discontinue the following tests:
- Test code 6055 – Spinocerebellar Ataxia Type 10 Repeat Expansion Analysis
- Test code 6054 – Spinocerebellar Ataxia Type 1 Repeat Expansion Analysis
- Test code 6027 – DRPLA Repeat Expansion Analysis
Baylor Genetics is a joint venture of H.U. Group Holdings and the #1 NIH-funded genetics program at Baylor College of Medicine. A pioneer of precision medicine for nearly 40 years, Baylor Genetics now offers a full spectrum of clinically relevant genetic testing, access to world-renowned experts, and the confidence to provide patients with the best care. Baylor Genetics, located in Houston’s Texas Medical Center, serves clients in 50 states and 16 countries.